Professor Jérôme Bertherat, endocrinologist at the Cochin Hospital in Paris (AP-HP), describes how the progress of personalized medicine is changing its practices in the treatment of endocrine cancers, and in particular adrenal cortical carcinoma.

Acute Myeloid Leukemia: identification of a new targeted therapy approach
Acute myeloid leukemia (AML) is a hematologic malignancy that develops from hematopoietic stem
